These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes-TAP report No. 3. Bressler NM; Arnold J; Benchaboune M; Blumenkranz MS; Fish GE; Gragoudas ES; Lewis H; Schmidt-Erfurth U; Slakter JS; Bressler SB; Manos K; Hao Y; Hayes L; Koester J; Reaves A; Strong HA; Arch Ophthalmol; 2002 Nov; 120(11):1443-54. PubMed ID: 12427056 [TBL] [Abstract][Full Text] [Related]
3. Guidelines for using verteporfin (visudyne) in photodynamic therapy to treat choroidal neovascularization due to age-related macular degeneration and other causes. ; ; Retina; 2002 Feb; 22(1):6-18. PubMed ID: 11884872 [TBL] [Abstract][Full Text] [Related]
4. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group. Arch Ophthalmol; 1999 Oct; 117(10):1329-45. PubMed ID: 10532441 [TBL] [Abstract][Full Text] [Related]
5. Guidelines for using verteporfin (Visudyne) in photodynamic therapy for choroidal neovascularization due to age-related macular degeneration and other causes: update. Verteporfin Roundtable Participants Retina; 2005; 25(2):119-34. PubMed ID: 15689800 [TBL] [Abstract][Full Text] [Related]
6. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynamic therapy report 2. Verteporfin In Photodynamic Therapy Study Group Am J Ophthalmol; 2001 May; 131(5):541-60. PubMed ID: 11336929 [TBL] [Abstract][Full Text] [Related]
7. Mechanisms of action of photodynamic therapy with verteporfin for the treatment of age-related macular degeneration. Schmidt-Erfurth U; Hasan T Surv Ophthalmol; 2000; 45(3):195-214. PubMed ID: 11094244 [TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study. Miller JW; Schmidt-Erfurth U; Sickenberg M; Pournaras CJ; Laqua H; Barbazetto I; Zografos L; Piguet B; Donati G; Lane AM; Birngruber R; van den Berg H; Strong A; Manjuris U; Gray T; Fsadni M; Bressler NM; Gragoudas ES Arch Ophthalmol; 1999 Sep; 117(9):1161-73. PubMed ID: 10496388 [TBL] [Abstract][Full Text] [Related]
9. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: meta-analysis of 2-year safety results in three randomized clinical trials: Treatment Of Age-Related Macular Degeneration With Photodynamic Therapy and Verteporfin In Photodynamic Therapy Study Report no. 4. Azab M; Benchaboune M; Blinder KJ; Bressler NM; Bressler SB; Gragoudas ES; Fish GE; Hao Y; Haynes L; Lim JI; Menchini U; Miller JW; Mones J; Potter MJ; Reaves A; Rosenfeld PJ; Strong A; Su XY; Slakter JS; Schmidt-Erfurth U; Sorenson JA; ; Retina; 2004 Feb; 24(1):1-12. PubMed ID: 15076937 [TBL] [Abstract][Full Text] [Related]
10. Macular translocation surgery with 360-degree peripheral retinectomy following ocular photodynamic therapy of choroidal neovascularization. Park CH; Toth CA Am J Ophthalmol; 2003 Nov; 136(5):830-5. PubMed ID: 14597033 [TBL] [Abstract][Full Text] [Related]
12. [Photodynamic therapy: Recommendations for indication and treatment]. Schmidt-Erfurth U; Laqua H Ophthalmologe; 2001 Feb; 98(2):216-9; quiz 230. PubMed ID: 11263053 [No Abstract] [Full Text] [Related]
13. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2. Bressler NM; Arch Ophthalmol; 2001 Feb; 119(2):198-207. PubMed ID: 11176980 [TBL] [Abstract][Full Text] [Related]
14. Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial. Azab M; Boyer DS; Bressler NM; Bressler SB; Cihelkova I; Hao Y; Immonen I; Lim JI; Menchini U; Naor J; Potter MJ; Reaves A; Rosenfeld PJ; Slakter JS; Soucek P; Strong HA; Wenkstern A; Su XY; Yang YC; Arch Ophthalmol; 2005 Apr; 123(4):448-57. PubMed ID: 15824216 [TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study. Schmidt-Erfurth U; Miller JW; Sickenberg M; Laqua H; Barbazetto I; Gragoudas ES; Zografos L; Piguet B; Pournaras CJ; Donati G; Lane AM; Birngruber R; van den Berg H; Strong HA; Manjuris U; Gray T; Fsadni M; Bressler NM Arch Ophthalmol; 1999 Sep; 117(9):1177-87. PubMed ID: 10496389 [TBL] [Abstract][Full Text] [Related]
16. Limited macular translocation compared with photodynamic therapy in the management of subfoveal choroidal neovascularization in age-related macular degeneration. Pawlak D; Glacet-Bernard A; Papp M; Roquet W; Coscas G; Soubrane G Am J Ophthalmol; 2004 May; 137(5):880-7. PubMed ID: 15126153 [TBL] [Abstract][Full Text] [Related]
17. Treatment of juxtafoveal choroidal neovascularization with photodynamic therapy using verteporfin in eyes with age-related macular degeneration. Hariprasad SM; Shah GK Ophthalmic Surg Lasers Imaging; 2005; 36(3):258-60. PubMed ID: 15957487 [TBL] [Abstract][Full Text] [Related]
18. Verteporfin : a review of its use in the management of subfoveal choroidal neovascularisation. Keam SJ; Scott LJ; Curran MP Drugs; 2003; 63(22):2521-54. PubMed ID: 14609361 [TBL] [Abstract][Full Text] [Related]
19. Submacular surgery trials randomized pilot trial of laser photocoagulation versus surgery for recurrent choroidal neovascularization secondary to age-related macular degeneration: I. Ophthalmic outcomes submacular surgery trials pilot study report number 1. Bressler NM; Bressler SB; Hawkins BS; Marsh MJ; Sternberg P; Thomas MA; Am J Ophthalmol; 2000 Oct; 130(4):387-407. PubMed ID: 11024412 [TBL] [Abstract][Full Text] [Related]